Desktop Site
|
24 Jul 24 | 11:02
|
Open
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
BSE SENSEX
80,325.71
-103.33
-0.13 %
Corporate Announcement
Security Code
543904
Company
Mankind Pharma Ltd
Exchange Received Time
18/07/2024 16:12:21
Exchange Disseminated Time
18/07/2024 16:12:23
Time Taken
00:00:02
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 |
7/18/2024 4:12:23 PM
Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of Board of Directors of the Company will be held on Wednesday, July 31, 2024, inter-alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30, 2024. Further, in continuation of our earlier letter dated June 26, 2024 under subject 'Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s ''Code of Conduct for Prevention of Insider Trading'', the trading window for trading in the securities of the Company shall remain closed till August 2, 2024. The above notice and details are also being uploaded on the website of the Company at www.mankindpharma.com.
Attachment
<< Back
Recently Viewed